A clinical study for evaluating the effects of lactic acid bacteria FK-23 on controlling intestinal functions (improvement of bowel movement)
- Conditions
- Healthy volunteers
- Registration Number
- JPRN-UMIN000021097
- Lead Sponsor
- Soiken Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Not provided
1)Subject receiving treatment for gastrointestinal diseases 2)Subject having a medical history with organic constipation or irritable bowel syndrome 3)Subject taken medicines for intestinal disorder or laxatives 4)Subject taking medicine, quasi-drugs, food for specified health uses or foods with functional claims having the effects for intestinal functions 5)Subject having serious liver diseases, cardiovascular, respiratory, endocrine or metabolic disorders, or having a medical history with them 6)Subject have a medical history with test food-ralated allergy 7)Female subject who is pregnant or lactating, or intending to become pregnant during the study 8)Subject who took part in another clinical study within 3 months prior to the start of the present study or who is currently taking part in another clinical study 9)Subject deemed unsuitable by the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method